Dr Amanda Farley PhD, MPhil, BSc

Dr Amanda Farley

Institute of Applied Health Research
Lecturer in Epidemiology

Contact details

Public Health, Epidemiology and Biostatistics
Institute of Applied Health Research
University of Birmingham
B15 2TT

Amanda Farley (nee Parsons) has worked as a research fellow at the University of Birmingham since 2003. Her research has centred around treatment for and health effects of smoking cessation. More recently, she has been developing interests in the area of supportive care for cancer survivors.


  • MPhil Brainstem pathophysiology in sudden infant death syndrome
    Brunel University, Uxbridge
  • BSc (hons) neurosciences
    UCLAN, Preston


Masters in Public Health (MPH) 

  • Module co-ordinator - Practical Epidemiology and Statistics
  • Lecturer - Epidemiology, Statistics and Research Methods 
  • Dissertation supervisor

Medicine and Surgery (MBChB

  • Evidence Based Medicine and Research Methods tutor
  • Communication skills tutor
  • Public health project supervisor

Medical Science (BMedSc

  • Project supervisor


Amanda is currently developing post doctoral study in the area of lung cancer survivorship. In particular she is interested in

  • The role of primary care services in identifying and treating ongoing post treatment needs
  • Treatment of post operative breathlessness
  • Role of inflammation in cancer progression

Since joining the university, Amanda has been involved in a range of projects. Some of these ongoing areas of research include:

(1) Describing and treating post cessation weight gain.
(2) Investigating the influence of continued smoking on health outcomes in chronic disease patients (particularly cancer, diabetes, mental health conditions)
(3) Effectiveness of brief intervention for weight control in Primary Care.
(4) Effectiveness of smoking reduction programmes delivered by pharmacists and general practitioners

Podcast: Interventions for preventing weight gain after smoking cessation

Other activities

Amanda has worked at a national level with the English Department of Health, the National Centre for Smoking Cessation Training and the National Institute of Clinical Excellence in projects surrounding the incorporation of smoking cessation support services into secondary care.


Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (online) 01/2014; 348:g1151. 

Aveyard P, Lycett D, Farley A (2012) Managing smoking cessation-related weight gain Pol Arch Med Wewn122: (10), 494 498

Di P, Farley A, Lindson N, Aveyard P (2012) Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV BMC Medicine in press

Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P (2012) Weight gain in smokers after quitting cigarettes: meta-analysis BMJ 345:e4439 doi: 10.1136/bmj.e4439

Aveyard P, Begh R, Parsons A, West R (2012) Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance Addiction 2012 doi:10.1111/j.1360-0443.2011.03770.x

Farley AC, Hajek P, Lycett D, Aveyard P.(2012) Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews Issue 1. Art. No.: CD006219. DOI: 10.1002/14651858.CD006219.pub3.Issue 1. Art. No.: CD006219. DOI: 10.1002/14651858.CD006219.pub3.

Parsons A, Daley A, Begh R, Aveyard P (2010) Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: a systematic review of observational studies with meta-analysis BMJ 340:b5569 doi:10.1136/bmj.b5569

Parsons A, Ingram J, Inglis J, Aveyard P, Johnstone E, Brown K, Franklin M, Bermudez I (2009) A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation Drug and Alcohol Dependence Jun 1;102(1-3):116-22

Aveyard P, Massey L, Parsons A, Manaseki S, Griffin C (2009) The effect of interventions based on the Transtheoretical Model on change in stage for smoking cessation and the relative effectiveness by baseline stage. Social Science & Medicine 2009; 68; 397-403

Aveyard P, Johnson C, Fillingham S, Parsons A, Murphy M. (2008) A pragmatic randomised controlled trial of nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation.  BMJ 336:1223-1227.